🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

[The effect of neuroprotectors on the level of BDNF, tumor necrosis factor alpha and apoptosis markers, and in acute cerebrovascular accidents].

PMID: 41782540 · DOI: 10.17116/jnevro2026126021123 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2026 · A V Shchulkin, I V Chernykh, Y V Abalenikhina, M V Gatsanoga, D L Kochetkova, N A Kruzhalov, E V Krestinina, E N Yakushe
📄 Abstract

To compare the effects of Mexidol, Cerebrolysin, and Cortexin on the levels of brain-derived neurotrophic factor (BDNF), tumor necrosis factor-alpha (TNF The study was performed on male Wistar rats. Right MCA occlusion-reperfusion was modeled using the method of J. Koizumi (1986). The occlusion duration was 60 minutes (1 hour). At the onset of reperfusion, animals were administered a single intravenous injection of either saline (control), or Mexidol (ethylmethylhydroxypyridine succinate) intravenously at a dose of 50 mg/kg, or Cerebrolysin intraperitoneally at a dose of 215 mg/kg, or Cortexin intraperitoneally at a dose of 1 mg/kg. Twenty-four hours after the start of reperfusion, the brain lesion volume was analyzed after staining with a 1% solution of 2.3,5-triphenyltetrazolium chloride. Western blotting was used to assess the levels of BDNF, TNF In the MCA occlusion-reperfusion model, the necrosis volume in the affected hemisphere of control animals was 38.16±5.98%. Mexidol reduced the necrosis volume to 20.48±2.33% ( Thus, when administered at the onset of reperfusion following MCA occlusion, Mexidol exerts the most pronounced cerebroprotective effect, stimulating neurogenesis and suppressing the development of neuroinflammation and apoptosis.

Confidence: 0.18 · 9 полей извлечено
Идентификация (6 полей)
Target
BDNF
0.95
Alt. target
brain-derived neurotrophic factor
0.95
Protein family
neurotrophin
0.90
Functional class
growth factor
0.90
Subcellular loc.
0.00
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
0.00
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
0.00
Downstream (physiol)
0.00
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
0.00
In vivo
Male Wistar rats subjected to right MCA occlusion-reperfusion (60 min occlusion) treated with Mexidol (50 mg/kg IV), Cerebrolysin (215 mg/kg IP), or Cortexin (1 mg/kg IP) at reperfusion onset. Outcomes assessed at 24h: brain lesion volume (TTC staining), BDNF, TNF-alpha, and apoptosis markers (Western blotting).
0.95
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
Male Wistar rats
1.00
Diet/model
Right MCA occlusion-reperfusion model (60 min occlusion, 24h reperfusion)
1.00
Клиника (11 полей)
Drug
Mexidol
0.90
Indication
acute cerebrovascular accidents
0.90
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00